Androgen Receptor Pathway Inhibitor

general

19

Centers

13

Active Trials

$3.9B

Cancer Funding

Specific Cancer Types(1)

NameCenters
Abiraterone Acetate19

Top Centers for Androgen Receptor Pathway Inhibitor(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
High-Volume Research Center
100.0
2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD
NCI Comprehensive
—
3
Duke Cancer InstituteDurham, NC
NCI Comprehensive
—
4
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
—
5
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
—
6
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
—
7
Huntsman Cancer Institute at the University of UtahSalt Lake City, UT
NCI Comprehensive
—
8
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
—
9
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
—
10
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
—
11
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
—
12
Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA
NCI Comprehensive
—
13
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
—
14
Boston University Cancer CenterBoston, MA
—
15
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
—
16
University of Cincinnati Cancer CenterCincinnati, OH
—
17
The University of Vermont Cancer CenterBurlington, VT
—
18
University of Texas Medical Branch Cancer CenterGalveston, TX
—
19
Louisiana Cancer Research CenterNew Orleans, LA
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →